Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jean Huang

Family Medicine Plano, TX Physician Assistant

NPI 1053877142 CMS profile 8796112

1524 Independence Pkwy Ste A1, Plano, TX 75075

Open in the dashboard

General payments

$5,406

549 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jean Huang of Plano, TX is reported in the CMS Open Payments database as having received $5,406 across 549 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $381 45
2024 General $808 100
2023 General $1,371 144
2022 General $1,371 116
2021 General $1,475 144

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jean Huang
  • Family Medicine median
  • Middle half of Family Medicine
  • National median

In program year 2025, general payments to Jean Huang were reported at $381. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.

Show as a table
Year Jean Huang Family Medicine median Middle half National median
2019 $0 $150 $41–$543 $163
2020 $0 $120 $32–$415 $114
2021 $1,475 $137 $35–$551 $132
2022 $1,371 $137 $37–$512 $149
2023 $1,371 $149 $42–$545 $160
2024 $808 $156 $44–$560 $164
2025 $381 $155 $45–$549 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Ironshore Pharmaceuticals Inc. $1,730 195 payments
  2. Neos Therapeutics, LP $1,057 119 payments
  3. Corium, Inc. $944 90 payments
  4. Tris Pharma Inc $785 71 payments
  5. Supernus Pharmaceuticals, Inc. $321 27 payments
  6. Noven Therapeutics, LLC $159 8 payments
  7. Collegium Pharmaceutical, Inc. $149 23 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $92 5 payments
  9. Jazz Pharmaceuticals Inc. $85 5 payments
  10. Adlon Therapeutics L.P. $29 2 payments
  11. Other $55 4 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,406 549 payments
Products named General payments · program years 2021–2025
  1. Adzenys XR-ODT $966 109 payments
  2. Azstarys $944 90 payments
  3. JORNAY PM Central Nervous Stimulant ADHD $917 88 payments
  4. JORNAY PM Central Nervous System Stimulant $813 107 payments
  5. COTEMPLA XR-ODT $391 40 payments
  6. Quillichew ER $380 35 payments
  7. QELBREE $321 27 payments
  8. Quillivant $239 23 payments
  9. ZolpiMist $221 20 payments
  10. Jornay PM Adhd $149 23 payments
  11. Other $586 37 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

549 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Family Medicine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record